CYTK – Cytokinetics, Incorporated
CYTK — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
14.3
Margin Of Safety %
Put/Call OI Ratio
0.18
EPS Next Q Diff
0.13
EPS Last/This Y
0.23
EPS This/Next Y
1.62
Price
76.72
Target Price
108.4
Analyst Recom
1.22
Performance Q
3.32
Upside
-429.2%
Beta
0.38
Ticker: CYTK
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | CYTK | 82.23 | 0.20 | 0.25 | 99868 |
| 2026-07-14 | CYTK | 81.93 | 0.20 | 0.04 | 101773 |
| 2026-07-15 | CYTK | 82.61 | 0.20 | 0.00 | 102858 |
| 2026-07-16 | CYTK | 80.33 | 0.19 | 0.05 | 106294 |
| 2026-07-17 | CYTK | 80.1 | 0.19 | 0.08 | 107351 |
| 2026-07-20 | CYTK | 79.09 | 0.18 | 0.07 | 73458 |
| 2026-07-21 | CYTK | 81.12 | 0.17 | 0.33 | 75817 |
| 2026-07-22 | CYTK | 82.23 | 0.17 | 0.06 | 76155 |
| 2026-07-23 | CYTK | 81.97 | 0.17 | 0.31 | 77793 |
| 2026-07-24 | CYTK | 80.71 | 0.17 | 0.11 | 77731 |
| 2026-07-27 | CYTK | 80.65 | 0.17 | 0.10 | 77779 |
| 2026-07-28 | CYTK | 79.46 | 0.17 | 0.11 | 79128 |
| 2026-07-29 | CYTK | 78.41 | 0.17 | 1.01 | 79267 |
| 2026-07-30 | CYTK | 80.43 | 0.17 | 0.07 | 79377 |
| 2026-07-31 | CYTK | 77.11 | 0.17 | 1.42 | 79452 |
| 2026-08-03 | CYTK | 76.45 | 0.17 | 0.74 | 79579 |
| 2026-08-04 | CYTK | 78.6 | 0.17 | 0.13 | 79707 |
| 2026-08-05 | CYTK | 78.89 | 0.18 | 0.22 | 79281 |
| 2026-08-06 | CYTK | 81.58 | 0.18 | 0.12 | 79291 |
| 2026-08-07 | CYTK | 76.72 | 0.18 | 0.59 | 79636 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | CYTK | 82.24 | -43.0 | -58.9 | -6.32 |
| 2026-07-14 | CYTK | 81.92 | -43.0 | -80.3 | -6.32 |
| 2026-07-15 | CYTK | 82.59 | -43.0 | -88.9 | -6.32 |
| 2026-07-16 | CYTK | 80.36 | -43.0 | -61.7 | -6.32 |
| 2026-07-17 | CYTK | 80.10 | -43.0 | -80.1 | -6.32 |
| 2026-07-20 | CYTK | 79.10 | -43.0 | -72.9 | -6.32 |
| 2026-07-21 | CYTK | 81.12 | -43.0 | -102.2 | -6.32 |
| 2026-07-22 | CYTK | 82.21 | -43.0 | -93.1 | -6.32 |
| 2026-07-23 | CYTK | 81.97 | -43.0 | -80.7 | -6.32 |
| 2026-07-24 | CYTK | 80.77 | -43.0 | -71.7 | -6.32 |
| 2026-07-27 | CYTK | 80.63 | -43.0 | -81.7 | -6.32 |
| 2026-07-28 | CYTK | 79.47 | -43.0 | -71.4 | -6.32 |
| 2026-07-29 | CYTK | 78.43 | -42.9 | -72.7 | -6.32 |
| 2026-07-30 | CYTK | 80.43 | -42.9 | -102.5 | -6.32 |
| 2026-07-31 | CYTK | 77.09 | -42.9 | -50.4 | -6.31 |
| 2026-08-03 | CYTK | 76.44 | -42.9 | -75.8 | -6.31 |
| 2026-08-04 | CYTK | 76.44 | -42.9 | -75.8 | -6.31 |
| 2026-08-05 | CYTK | 78.88 | -42.9 | -85.3 | -6.31 |
| 2026-08-06 | CYTK | 81.47 | -42.9 | -107.8 | -6.31 |
| 2026-08-07 | CYTK | 76.72 | -42.9 | -37.6 | -6.31 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | CYTK | -6.94 | 5.04 | 14.74 |
| 2026-07-14 | CYTK | -7.07 | 5.04 | 14.74 |
| 2026-07-15 | CYTK | -7.07 | 5.04 | 14.74 |
| 2026-07-16 | CYTK | -7.07 | 5.04 | 14.74 |
| 2026-07-17 | CYTK | -7.07 | 5.04 | 14.74 |
| 2026-07-20 | CYTK | -7.07 | 2.56 | 14.74 |
| 2026-07-21 | CYTK | -7.07 | 2.56 | 14.74 |
| 2026-07-22 | CYTK | -7.07 | 2.56 | 14.74 |
| 2026-07-23 | CYTK | -7.07 | 2.56 | 14.74 |
| 2026-07-24 | CYTK | -7.13 | 2.56 | 14.74 |
| 2026-07-27 | CYTK | -7.13 | 2.57 | 14.30 |
| 2026-07-28 | CYTK | -7.25 | 2.57 | 14.30 |
| 2026-07-29 | CYTK | -7.25 | 2.57 | 14.30 |
| 2026-07-30 | CYTK | -7.25 | 2.57 | 14.30 |
| 2026-07-31 | CYTK | -7.48 | 2.57 | 14.30 |
| 2026-08-03 | CYTK | -7.47 | 3.45 | 14.30 |
| 2026-08-04 | CYTK | -7.47 | 3.45 | 14.30 |
| 2026-08-05 | CYTK | -7.47 | 3.45 | 14.30 |
| 2026-08-06 | CYTK | -7.22 | 3.45 | 14.30 |
| 2026-08-07 | CYTK | -7.22 | 3.45 | 14.30 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.67
Avg. EPS Est. Current Quarter
-1.6
Avg. EPS Est. Next Quarter
-1.54
Insider Transactions
-7.22
Institutional Transactions
3.45
Beta
0.38
Average Sales Estimate Current Quarter
16
Average Sales Estimate Next Quarter
27
Fair Value
Quality Score
8
Growth Score
50
Sentiment Score
68
Actual DrawDown %
30.4
Max Drawdown 5-Year %
-72.4
Target Price
108.4
P/E
Forward P/E
PEG
P/S
141.15
P/B
P/Free Cash Flow
EPS
-7.22
Average EPS Est. Cur. Y
-6.31
EPS Next Y. (Est.)
-4.69
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1321.12
Relative Volume
1.58
Return on Equity vs Sector %
73
Return on Equity vs Industry %
89.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
-37.6
◆
CYTK
Healthcare
$76.76
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
43
Range 1M
19.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
6.9%
EPS NY
26.9%
52W%
79.9%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+41.2% upside
Upside
+41.2%
Quality
8
CYTK — P/E HistoricalBiotechnology
Cytokinetics, IncorporatedSector: Healthcare
Industry: Biotechnology
Employees: 673
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
CYTK
Latest News
—
Caricamento notizie per CYTK…
stock quote shares CYTK – Cytokinetics, Incorporated Stock Price stock today
news today CYTK – Cytokinetics, Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch CYTK – Cytokinetics, Incorporated yahoo finance google finance
stock history CYTK – Cytokinetics, Incorporated invest stock market
stock prices CYTK premarket after hours
ticker CYTK fair value insiders trading